UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies

BMC cancer, 2013-03, Vol.13 (1), p.152-152, Article 152

2013

Volltextzugriff (PDF)

Randomized Phase III Study of Trastuzumab, Paclitaxel, and Carboplatin Compared With Trastuzumab and Paclitaxel in Women With HER-2–Overexpressing Metastatic Breast Cancer

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2786-2792

2006

Volltextzugriff (PDF)

Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma

PloS one, 2012-05, Vol.7 (5), p.e37029-e37029

2012

Volltextzugriff (PDF)

R‐CHOP with iodine‐131 tositumomab consolidation for advanced stage diffuse large B‐cell lymphoma (DLBCL): SWOG S0433

British journal of haematology, 2014-08, Vol.166 (3), p.382-389

2014

Volltextzugriff (PDF)

Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer

Journal of thoracic oncology, 2010-12, Vol.5 (12), p.1963-1969

2010

Volltextzugriff (PDF)

Pemetrexed in Relapsed Small-Cell Lung Cancer and the Impact of Shortened Vitamin Supplementation Lead-In Time: Results of a Phase II Trial

Journal of thoracic oncology, 2008-11, Vol.3 (11), p.1308-1316

2008

Volltextzugriff (PDF)

Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium

Investigational new drugs, 2008-04, Vol.26 (2), p.151-158

2008

Volltextzugriff (PDF)

Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2005, Vol.47 (1), p.121-127

2005

Volltextzugriff (PDF)

Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma

Blood, 2010-01, Vol.115 (3), p.475-480

2010

Volltextzugriff (PDF)

A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer

International journal of oncology, 2014-12, Vol.45 (6), p.2221-2231

2014

Volltextzugriff (PDF)

R ‐ CHOP with iodine‐131 tositumomab consolidation for advanced stage diffuse large B ‐cell lymphoma ( DLBCL ): SWOG S 0433

British journal of haematology, 2014-08, Vol.166 (3), p.382-389

2014

Volltextzugriff (PDF)

IN VITRO ANTIBACTERIAL POTENTIAL OF HALOPHILIC BACTERIAL SECONDARY METABOLITES FROM SALTED FISH

International journal of pharmaceutical sciences and drug research, 2016-07, p.235-239

2016

Volltextzugriff (PDF)

A phase 1 study of MM-111, a bispecific HER2/HER3 antibody fusion protein, combined with multiple treatment regimens in patients with advanced HER2-positive solid tumors

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.651-651

2014

Volltextzugriff (PDF)

A phase I and pharmacologic study of MM-111, a bispecific HER2/HER3 antibody fusion protein, in combination with multiple treatment regimens in patients with advanced HER2-positive solid tumors

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS3111-TPS3111

2012

Volltextzugriff (PDF)

Results of a Phase II Study of Bortezomib in Patients with Relapsed or Refractory Indolent Lymphoma

Blood, 2008-11, Vol.112 (11), p.1572-1572

2008

Volltextzugriff (PDF)

P1-229: The impact of shortened vitamin supplementation lead-in time before pemetrexed (P) in patients with relapsed small-cell lung cancer (SCLC)

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S829-S830

2007

Volltextzugriff (PDF)

Phase 1 Study of Talabostat and Rituximab in Patients with Indolent Non-Hodgkin's Lymphoma with Primary Resistance to or Progression Following Rituximab

Blood, 2004-11, Vol.104 (11), p.1403-1403

2004

Volltextzugriff (PDF)

Pseudo-Gaucher cells in the bone marrow of a patient with Hodgkin's disease

American journal of clinical pathology, 1987-04, Vol.87 (4), p.533-536

1987

Volltextzugriff (PDF)

Pleural effusion in breast carcinoma: Analysis of 122 cases

Cancer, 1981-12, Vol.48 (11), p.2524-2527

1981

Volltextzugriff (PDF)

Radiation‐induced leiomyosarcoma of the great vessels presenting as superior vena cava syndrome

Cancer, 1987-09, Vol.60 (6), p.1238-1242

1987

Volltextzugriff (PDF)

ViVACCy—A Drug Schedule Based on G2 Blockade and Prolonged Infusion of Multiple Tubulin‐Binding Agents A Pilot Study

Cancer, 1990-08, Vol.66 (3), p.411-417

1990

Volltextzugriff (PDF)

Treatment of six cases of mesothelioma with doxorubicin and cisplatin

Cancer, 1983-11, Vol.52 (10), p.1788-1791

1983

Volltextzugriff (PDF)

Chemoendocrine therapy vs chemotherapy alone for advanced breast cancer in postmenopausal women: Preliminary report of a randomized study: Cancer and Leukemia Group B Study 8081

Breast cancer research and treatment, 1983-12, Vol.3 (4), p.365-371

1983

Volltextzugriff (PDF)

Lactic acidosis in lung cancer

Southern medical journal (Birmingham, Ala.), 1983-03, Vol.76 (3), p.397-398

1983

Volltextzugriff (PDF)

Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop

Obstetrics and gynecology (New York. 1953), 2016-03, Vol.127 (3), p.426-436

2016

Volltextzugriff (PDF)

1 – 25 von 810

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(696)
Mit Volltextzugriff
(689)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(806)
Deutsch
(4)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(479)
Life Sciences & Biomedicine
(351)
Humans
(255)
Female
(138)
Male
(132)
Animals
(92)
Biological And Medical Sciences
(87)
Physical Sciences
(79)
Middle Aged
(76)
Adult
(75)
Medical Sciences
(67)
Aged
(66)
Chemistry
(58)
Technology
(49)
Mice
(46)
Biochemistry & Molecular Biology
(44)
Science & Technology - Other Topics
(44)
Oncology
(42)
Mutation
(38)
Cell Biology
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies

Randomized Phase III Study of Trastuzumab, Paclitaxel, and Carboplatin Compared With Trastuzumab and Paclitaxel in Women With HER-2–Overexpressing Metastatic Breast Cancer

Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma

R‐CHOP with iodine‐131 tositumomab consolidation for advanced stage diffuse large B‐cell lymphoma (DLBCL): SWOG S0433

Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer

Pemetrexed in Relapsed Small-Cell Lung Cancer and the Impact of Shortened Vitamin Supplementation Lead-In Time: Results of a Phase II Trial

Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium

Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma

A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer

R ‐ CHOP with iodine‐131 tositumomab consolidation for advanced stage diffuse large B ‐cell lymphoma ( DLBCL ): SWOG S 0433

IN VITRO ANTIBACTERIAL POTENTIAL OF HALOPHILIC BACTERIAL SECONDARY METABOLITES FROM SALTED FISH

A phase 1 study of MM-111, a bispecific HER2/HER3 antibody fusion protein, combined with multiple treatment regimens in patients with advanced HER2-positive solid tumors

A phase I and pharmacologic study of MM-111, a bispecific HER2/HER3 antibody fusion protein, in combination with multiple treatment regimens in patients with advanced HER2-positive solid tumors

Results of a Phase II Study of Bortezomib in Patients with Relapsed or Refractory Indolent Lymphoma

P1-229: The impact of shortened vitamin supplementation lead-in time before pemetrexed (P) in patients with relapsed small-cell lung cancer (SCLC)

Phase 1 Study of Talabostat and Rituximab in Patients with Indolent Non-Hodgkin's Lymphoma with Primary Resistance to or Progression Following Rituximab

Pseudo-Gaucher cells in the bone marrow of a patient with Hodgkin's disease

Pleural effusion in breast carcinoma: Analysis of 122 cases

Radiation‐induced leiomyosarcoma of the great vessels presenting as superior vena cava syndrome

ViVACCy—A Drug Schedule Based on G2 Blockade and Prolonged Infusion of Multiple Tubulin‐Binding Agents A Pilot Study

Treatment of six cases of mesothelioma with doxorubicin and cisplatin

Chemoendocrine therapy vs chemotherapy alone for advanced breast cancer in postmenopausal women: Preliminary report of a randomized study: Cancer and Leukemia Group B Study 8081

Lactic acidosis in lung cancer

Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop

Suchergebnisse filtern